Kidney Res Clin Pract.
2022 Nov;41(6):768-770. 10.23876/j.krcp.22.218.
Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir/ritonavir) administration in a kidney transplant recipient
- Affiliations
-
- 1Division of Nephrology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
- 2Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
- 3Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
- 4Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea
- KMID: 2540205
- DOI: http://doi.org/10.23876/j.krcp.22.218
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Acute kidney injury in kidney transplant recipients with active SARS-CoV-2 infection due to drug interaction of tacrolimus and nirmatrelvir/ritonavir: three serial case reports
- Nirmatrelvir/Ritonavir Prescription Rate and Outcomes in Coronavirus Disease 2019: A Single Center Study
- Determining and Comparing the RealWorld Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Patients Hospitalized With COVID-19
- Effect of Paxlovid in COVID-19 treatment during the periods of SARS-CoV-2 Omicron BA.5 and BN.1 subvariant dominance in the Republic of Korea: a retrospective cohort study
- Treatment Options for Patients With Mild-to-Moderate Coronavirus Disease 2019 in Korea
